Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1055

Feb 13, 2021

Humanity’s Best Friend: How Dogs Could Be Our Next Allies in the Fight Against COVID-19

Posted by in category: biotech/medical

Dogs’ Highly Evolved Noses Can Rapidly Detect the SARS-CoV-2 Virus For some 15000 years, dogs have been our hunting partners, workmates, helpers and companions. Could they also be our next allies in the fight against COVID-19? According to UC Santa Barbara professor emeritus Tommy Dickey and his collaborator, BioScent researcher Heather Junqueira, they can. And with a review paper published in the Journal of Osteopathic Medicine they have added to a small but growing consensus that trained medical scent dogs can effectively be used for screening individuals who may be infected with the COVID-19 virus.

Feb 13, 2021

Bill Gates, who predicted the pandemic, names the next two monster disasters that could shake our world

Posted by in categories: biotech/medical, climatology, sustainability, terrorism

In a recent interview, he said the next big disasters facing humanity are climate change and bioterrorism.


Gates was asked about the next crises the world may have to confront.

Continue reading “Bill Gates, who predicted the pandemic, names the next two monster disasters that could shake our world” »

Feb 13, 2021

Buddhism in Huxley’s Evolution and Ethics

Posted by in categories: biotech/medical, ethics, evolution, life extension

Julian Huxley was part of the intellectual dynasty started by TH Huxley, and is more influenced by Buddhist ideas than Judeo-Christian. “T. H. Huxley was a paleontologist with a medical background who gained great prominence in the nineteenth century as one of the foremost defenders of Darwin’s evolutionary theory. Victorians were often inclined to see him as “the living embodiment of science militant,”(8) for Huxley actually clashed with contemporary defenders of Biblical supernaturalism in the name of science.(9) A very late product of his intellectual career, Evolution and Ethics (1893) shows him in a mellowed, reflective mood. The radical disjunction between the ethical and the cosmic processes such as is frequently highlighted here hardly squares with “orthodox” Darwinism; in fact Irvine has called Huxley’s effort in this context a “somewhat puzzling manoeuvre” that is “full of talk about Indian mysticism and of protest about the cruelties of evolution.”(10) Yet his overall treatment of his theme is not a matter that need concern us now.(11) What must be noted, on the other hand, is that in the course of his professed endeavor to inquire into the origin and the basis of ethical values from an evolutionary standpoint, Huxley indeed undertook a brief survey of the leading philosophies that had helped to form mankind’s conceptions of such values. He emphasized in this connection that India had engendered a distinctive outlook on life, and some of the ideas central to that outlook (as, for example, karman) actually made a notable impression on him. But it is upon a particular religion of Indian origin, namely Buddhism, that he chose to dwell at length and, I think, in a way that merits close attention.” Buddhism is” system which knows no God in the Western sense; which denies a soul to man; which counts the belief in immortality a blunder and hope of it a sin; which refuses any efficacy to prayer and sacrifice; which bids men look to nothing but their own efforts for salvation; which in its original purity, knew nothing of vows of obedience, abhorred intolerance, and never sought the aid of the secular arm; yet spread over a considerable moiety of the Old World with marvellous rapidity, and is still, with whatever base admixure of foreign superstitions, the dominant creed of a large fraction of mankind.”


A note on a Victorian evaluation and its “comparativist dimension” By Vijitha Rajapakse Philosophy East and West Volume 35, no. 3 (July 1985)

©by the University of Hawaii Press

Continue reading “Buddhism in Huxley’s Evolution and Ethics” »

Feb 12, 2021

The broken promise that undermines human genome research

Posted by in category: biotech/medical

Although some researchers are reluctant to share genome data, the field is generally viewed as generous compared with other disciplines. Still, the repositories meant to foster sharing often present barriers to those uploading and downloading data. Researchers tell tales of spending months or years tracking down data sets, only to find dead ends or unusable files. And journal editors and funding agencies struggle to monitor whether scientists are sticking to their agreements.


Data sharing was a core principle that led to the success of the Human Genome Project 20 years ago. Now scientists are struggling to keep information free.

Feb 12, 2021

BenevolentAI doses first patient in atopic dermatitis drug trial

Posted by in category: biotech/medical

UK-based BenevolentAI has dosed the first patient in its first-in-human clinical trial of its novel multi-target drug, BEN-2293, for treating atopic dermatitis (AD).

Designed and developed using BenevolentAI’s scientific and technical expertise, BEN-2293 is a potent and selective small-molecule Pan-Trk antagonist formulated for topical delivery.


BenevolentAI has dosed the first patient in its clinical trial of its novel multi-target drug, BEN-2293, for treating atopic dermatitis (AD).

Feb 12, 2021

Should you mix and match COVID-19 vaccines? Scientists are seeking answers

Posted by in category: biotech/medical

With nine vaccines now showing they can powerfully prevent severe illness and death from #COVID19—and vaccines in short supply—researchers are mulling an issue that, even a few months ago, was only hypothetical: Should people mix and match vaccines that require two shots?


Scarce vaccine supplies ramp up interest in combining different doses.

Feb 12, 2021

New Israeli Drug Could Hold a Key to Stopping the COVID-19 Pandemic

Posted by in categories: biotech/medical, innovation

An Israeli drug that has been successful in initial trials, could hold a key in blunting the COVID-19 pandemic. Thirty patients in serious condition participated in the trial and all recovered, most of them in less than a week. Sonya Cohen was one of them and she could one day be seen as a walking #miracle.

Follow Jerusalem Dateline and download the CBN News app to ensure you keep receiving news from a Christian Perspective. go.cbn.com/cbnapp.

#covidcure #Israel #Israeli #innovation #fightcovid #breakthrough.
Ichilov Hospital, Tel Aviv

Feb 12, 2021

Scientists are already making vaccines for the next pandemic, whatever it may be

Posted by in categories: biotech/medical, futurism

Many researchers are already working on developing vaccines for the next pandemic, even though they don’t know what it will be. (Craig Chivers/CBC.


When the next coronavirus pandemic hits, scientists plan to already have a vaccine against it, no matter what it is. But how is that possible? Here’s what they’re doing now to develop vaccines against emerging viruses and future variants of COVID-19.

Feb 12, 2021

Popular Energy Drinks’ Harmful Effects on Heart Revealed in New Research

Posted by in categories: biotech/medical, chemistry, food

Popular energy drinks may give you a boost, but they may also contribute to possible serious heart conditions, findings show.

A team of researchers, led by a Texas A&M University professor, has found that some energy drinks have adverse effects on the muscle cells of the heart.

The study, led by Dr. Ivan Rusyn, a professor in the Veterinary Integrative Biosciences (VIBS) Department at the Texas A&M College of Veterinary Medicine & Biomedical Sciences (CVMBS), was published in Food and Chemical Toxicology. In it, researchers observed cardiomyocytes – human heart cells grown in a laboratory – exposed to some energy drinks showed an increased beat rate and other factors affecting cardiac function.

Feb 12, 2021

Aging industry blindspots | S Arrison, 100 Plus Capital, K Pfleger, AgingBiotech.info, M West, AgeX

Posted by in categories: biotech/medical, economics, life extension, robotics/AI, singularity

57:03 “A tool that would be used for millenia.”


Foresight biotech & health extension group sponsored by 100 plus capital.

Continue reading “Aging industry blindspots | S Arrison, 100 Plus Capital, K Pfleger, AgingBiotech.info, M West, AgeX” »